Early Phase 1 Stroke Trial, Recruiting NCT06656754 Sponsor: Shirley Ryan AbilityLab Condition: Stroke
Back to Stroke

Early Phase 1 Stroke Trial, Recruiting

NCT06656754
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people without a history of stroke (neurotypical participants):

  • People who are 18 years old or older
  • People who have no history of stroke
  • People who are able to give their own informed consent to participate

For people who have had a stroke (stroke participants):

  • People who are 18 years old or older
  • People who had their stroke at least 8 months ago
  • People who have available medical records and brain scan information showing where the stroke occurred
  • People who have weakness or reduced movement on one side of the body
  • People whose stroke affected the primary motor area of the brain
  • People who have some ability to move both the shoulder and elbow on the affected side

Who may not be able to join:

For people without a history of stroke (neurotypical participants):

  • People with serious medical conditions, including heart, bone and joint, or neurological problems
  • People with medical conditions that affect movement, range of motion, strength, or coordination of the arms and hands
  • People with vision problems that would affect their ability to complete the experiment — vision and depth perception will be tested using standardised assessments (confirm with trial site for exact cut-off scores)
  • People with blood pressure above 140 (top number) and/or 90 (bottom number)
  • People with a blood oxygen level below 92% as measured by a finger pulse reader

For people who have had a stroke (stroke participants):

  • People who have weakness or reduced movement on both sides of the body
  • People with communication difficulties, cognitive impairment, or emotional or behavioural changes that would affect their ability to take part — this will be assessed using a standardised memory and thinking test, with cut-off scores that vary depending on education level (confirm with trial site)
  • People with vision problems or difficulty noticing things on one side of their visual field that would prevent them from seeing targets during the experiment — this will be assessed using standardised vision and attention tests (confirm with trial site for exact cut-off scores)
  • People with a muscle stiffness score of 4 at the shoulder or elbow on a standard clinical scale
  • People who score below 15 on a standard arm movement assessment scale
  • People who are unable to give their own informed consent
  • People with serious current medical problems
  • People with severe loss of sensation in the affected arm
  • People whose stroke caused damage in multiple or widespread areas of the brain, or who have had more than one stroke
  • People who are unable to get into or hold the positions required for testing
  • People who have received Botox or similar injections in the affected arm within the past 4 months
  • People who are currently taking part in any other arm rehabilitation programme, whether as part of a research study or as a prescribed therapy
  • People with other neurological, neuromuscular, or bone and joint conditions affecting the arm or hand
  • People with other neurological conditions such as Parkinson's disease or cerebral palsy
  • People with blood pressure above 140 (top number) and/or 90 (bottom number)
  • People with a blood oxygen level below 92% as measured by a finger pulse reader

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: James L Patton, PhD, Shirley Ryan AbilityLab

Phone: 312-238-1379

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Shirley Ryan AbilityLab
Registry
ClinicalTrials.gov
Start date
17 November 2024
Est. completion
1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perpendicular Error

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov